应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
ABBV 艾伯维公司
交易中 07-01 09:34:38 EDT
249.83
-1.56
-0.62%
最高
251.51
最低
249.51
成交量
16.38万
今开
250.62
昨收
251.39
日振幅
0.80%
总市值
4,415亿
流通市值
4,404亿
总股本
17.67亿
成交额
4,100万
换手率
0.01%
流通股本
17.63亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
美国众议院委员会就中国药物临床试验展开调查后，默沙东、艾伯维股价盘前下跌。默克股价下跌1.2%，艾伯维股价下跌1%。
智通财经 · 06-30 18:07
美国众议院委员会就中国药物临床试验展开调查后，默沙东、艾伯维股价盘前下跌。默克股价下跌1.2%，艾伯维股价下跌1%。
独家：美国议员发函要求获取近十年数百项试验文件，含数据保护流程
美股速递 · 06-30 18:03
独家：美国议员发函要求获取近十年数百项试验文件，含数据保护流程
艾伯维宣布Epcoritamab联合来那度胺在复发或难治性弥漫性大B细胞淋巴瘤患者中取得积极三期试验结果
美股速递 · 06-30 04:53
艾伯维宣布Epcoritamab联合来那度胺在复发或难治性弥漫性大B细胞淋巴瘤患者中取得积极三期试验结果
艾伯维公司Rinvoq®获欧盟CHMP积极意见 用于治疗成人和青少年非节段型白癜风
美股速递 · 06-29 15:08
艾伯维公司Rinvoq®获欧盟CHMP积极意见 用于治疗成人和青少年非节段型白癜风
一周美股牛榜 | Bio-Techne上周飙涨逾22%，艾伯维公司劲升逾17%，联合大陆航空涨超15%，康宁涨超13%
老虎资讯综合 · 06-29 10:18
一周美股牛榜 | Bio-Techne上周飙涨逾22%，艾伯维公司劲升逾17%，联合大陆航空涨超15%，康宁涨超13%
异动解读｜艾伯维公司盘中上涨3.31%，109亿美元收购Apogee叠加多重产品获批持续提振
行情直击 · 06-27
异动解读｜艾伯维公司盘中上涨3.31%，109亿美元收购Apogee叠加多重产品获批持续提振
异动解读｜艾伯维公司盘中上涨3.23%，109亿美元收购Apogee持续提振叠加多重利好
行情直击 · 06-25
异动解读｜艾伯维公司盘中上涨3.23%，109亿美元收购Apogee持续提振叠加多重利好
医美巨头证实“司美格鲁肽脸”真实存在 新上市再生医美公司欲入局分羹
美股速递 · 06-25
医美巨头证实“司美格鲁肽脸”真实存在 新上市再生医美公司欲入局分羹
艾伯维-爱力根美学部门将启动培训，为未来数月内Boey的商业上市做准备
美股速递 · 06-23
艾伯维-爱力根美学部门将启动培训，为未来数月内Boey的商业上市做准备
艾伯维宣布Maviret®获欧盟批准用于治疗急性丙型肝炎病毒感染
美股速递 · 06-23
艾伯维宣布Maviret®获欧盟批准用于治疗急性丙型肝炎病毒感染
艾伯维(ABBV)免疫产品SKYRIZI获欧盟批准 扩展至儿童与青少年中重度斑块状银屑病范畴
金吾财讯 · 06-23
艾伯维(ABBV)免疫产品SKYRIZI获欧盟批准 扩展至儿童与青少年中重度斑块状银屑病范畴
艾伯维公司宣布欧盟委员会批准Skyrizi®（瑞莎珠单抗）用于治疗中重度斑块状银屑病儿科患者
美股速递 · 06-23
艾伯维公司宣布欧盟委员会批准Skyrizi®（瑞莎珠单抗）用于治疗中重度斑块状银屑病儿科患者
AbbVie以109亿美元收购Apogee Therapeutics
老虎资讯综合 · 06-23
AbbVie以109亿美元收购Apogee Therapeutics
109亿美元豪赌下一代“药王”！艾伯维溢价49%收购Apogee，剑指赛诺菲Dupixent
智通财经 · 06-22
109亿美元豪赌下一代“药王”！艾伯维溢价49%收购Apogee，剑指赛诺菲Dupixent
异动解读｜艾伯维盘中上涨3.24%，拟109亿美元收购Apogee强化免疫学管线
行情直击 · 06-22
异动解读｜艾伯维盘中上涨3.24%，拟109亿美元收购Apogee强化免疫学管线
艾伯维CEO称Apogee收购是“绝佳契合”，符合构建产品管线及为2030年代以后增添新增长动力的战略
美股速递 · 06-22
艾伯维CEO称Apogee收购是“绝佳契合”，符合构建产品管线及为2030年代以后增添新增长动力的战略
溢价高达60%！艾伯维拟109亿美元收购Apogee，最快今日官宣
智通财经 · 06-22
溢价高达60%！艾伯维拟109亿美元收购Apogee，最快今日官宣
据《金融时报》报道，根据正在讨论的协议条款，艾伯维将以109亿美元现金收购Apogee股东股权
美股速递 · 06-19
据《金融时报》报道，根据正在讨论的协议条款，艾伯维将以109亿美元现金收购Apogee股东股权
艾伯维旗下爱力根美学获FDA批准，Juvéderm® Skinvive用于改善颈部外观
美股速递 · 06-16
艾伯维旗下爱力根美学获FDA批准，Juvéderm® Skinvive用于改善颈部外观
异动解读｜艾伯维公司盘中下跌3.07%，报222.22美元
行情直击 · 06-15
异动解读｜艾伯维公司盘中下跌3.07%，报222.22美元
加载更多
公司概况
公司名称：
艾伯维公司
所属市场：
NYSE
上市日期：
--
主营业务：
艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。
发行价格：
--
{"stockData":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯维公司","latestPrice":249.825,"timestamp":1782912876942,"preClose":251.39,"halted":0,"volume":163801,"delay":0,"changeRate":-0.00622538684911889,"floatShares":1762950764,"shares":1767384632,"eps":2.030053,"marketStatus":"交易中","change":-1.565,"latestTime":"07-01 09:34:38 EDT","open":250.62,"high":251.51,"low":249.51,"amount":41003942.329789996,"amplitude":0.007956,"askPrice":249.94,"askSize":200,"bidPrice":249.45,"bidSize":10,"shortable":3,"etf":0,"ttmEps":2.030053,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1782936000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":251.39,"dividendRate":0.026979,"preHourTrading":{"tag":"盘前","latestPrice":251.1001,"preClose":251.39,"latestTime":"09:29 EDT","volume":1377,"amount":346236.83199,"timestamp":1782912567074,"change":-0.2899,"changeRate":-0.001153,"amplitude":0.011496},"postHourTrading":{"tag":"盘后","latestPrice":251.346,"preClose":251.64,"latestTime":"19:59 EDT","volume":542238,"amount":136447037.1617,"timestamp":1782863971559,"change":-0.294,"changeRate":-0.001168,"amplitude":0.001788},"volumeRatio":0.73438,"impliedVol":0.3042,"impliedVolPercentile":0.757},"requestUrl":"/m/hq/s/ABBV","defaultTab":"news","newsList":[{"id":"2647017534","title":"美国众议院委员会就中国药物临床试验展开调查后，默沙东、艾伯维股价盘前下跌。默克股价下跌1.2%，艾伯维股价下跌1%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2647017534","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647017534?lang=zh_cn&edition=full","pubTime":"2026-06-30 18:07","pubTimestamp":1782814066,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0912757837.SGD","LU0456855351.SGD","LU0965509010.AUD","LU0511384066.AUD","LU2087621335.USD","LU2361044865.SGD","LU0211331839.USD","LU2491050154.USD","LU0122379950.USD","IE0009355771.USD","SG9999013999.USD","LU1093756168.USD","IE00BGHQF631.EUR","LU1923622614.USD","LU0256863902.USD","IE00BJJMRZ35.SGD","LU0130102774.USD","IE00B1BXHZ80.USD","BK4516","LU1061106388.HKD","LU1162221912.USD","LU0738911758.USD","LU1244550494.USD","IE00B19Z3B42.SGD","LU0795875169.SGD","BK4533","LU0265550359.USD","LU0965509101.SGD","SG9999002232.USD","LU0472753341.HKD","LU1917777945.USD","LU2125154778.USD","LU2023250843.SGD","LU1116320901.HKD","LU2089984988.USD","LU2106854487.HKD","IE00BFTCPJ56.SGD","LU0234570918.USD","LU1201861249.SGD","IE00BVYPNV92.GBP","LU0859254822.USD","LU1066051811.HKD","LU0868494708.USD","LU0289739699.SGD","LU2237443978.SGD","SG9999011175.SGD","LU2125909593.SGD","SG9999014559.SGD","LU1983299246.USD","LU1989772923.USD","IE00B3PB1722.GBP","LU1670628061.USD","LU1670627923.USD","LU0029864427.USD","IE000M9KFDE8.USD","IE00B2B36J28.USD","LU0198837287.USD","BK4007","LU1037948897.HKD","IE0002141913.USD","LU1093756325.SGD","SG9999015945.SGD","IE000SO60NU8.SGD","LU0070302665.USD","IE00B4R5TH58.HKD","LU2237443465.HKD","LU1551013342.USD","LU0648001328.SGD","LU1057294990.SGD","LU1941712348.USD","IE00BLSP4239.USD","LU1430594728.SGD","LU0949170772.SGD","LU2491050071.SGD","LU1267930490.SGD","LU1074936037.SGD","LU0320765646.SGD","LU2023250504.SGD","BK4534","SG9999003800.SGD","LU2089283258.USD","LU0069063385.USD","LU1244550577.SGD","SG9999015358.SGD","IE00BLSP4452.SGD","BK4581","BK4559","SG9999001176.USD","IE00BN8TJ469.HKD","LU0942090050.USD","LU2125154935.USD","IE00BBT3K403.USD","LU1571399168.USD","SG9999001176.SGD","LU1585245621.USD","LU1066051498.USD","LU2361045086.USD","LU0130517989.USD","LU0203347892.USD","IE00BVYPNW00.USD","LU1839511570.USD","LU0114720955.EUR","LU0868494617.USD","LU1934455863.HKD","LU2089284900.SGD","SG9999002224.SGD","LU0477156953.USD","BK4585","LU0158827948.USD","LU0823416689.USD","LU0238689110.USD","LU1267930573.SGD","LU2461242641.AUD","LU2360032135.SGD","IE00BDGV0183.EUR","LU1496350502.SGD","LU2237443549.SGD","LU1066051225.USD","LU0820561818.USD","LU0965508806.USD","LU0170899867.USD","LU2357627491.SGD","BK4139","IE0002270589.USD","LU1037948541.HKD","LU0124676726.USD","LU1496350171.SGD","BK4566","LU1989772840.SGD","LU2129689431.USD","LU1291159041.SGD","IE000F7OJYX1.SGD","LU1116320737.USD","LU0256863811.USD","ABBV","LU1732799900.SGD","LU1244550221.USD","LU0289961442.SGD","IE00B19Z3581.USD","LU0985320562.USD","LU0545039389.USD","LU0795875086.SGD","SG9999015986.USD","LU2361044949.HKD","LU0661504455.SGD","LU1934455194.USD","SG9999015978.USD","LU1003077747.HKD","LU2237443622.USD","LU0234572021.USD","LU2468319806.SGD","LU0943347566.SGD","LU2133065610.SGD","IE00BSNM7G36.USD","LU2125909247.SGD","SG9999015341.SGD","LU0861579265.USD","LU0417517546.SGD","LU0689472784.USD","LU1035773651.USD","LU2129689605.HKD","SG9999001440.SGD","LU0689626769.HKD","LU1989771016.USD","LU2129689514.USD","LU0208291251.USD","LU0098860793.USD","LU0432979614.USD","LU2237443895.HKD","LU2023251221.USD","IE00BJT1NW94.SGD","LU1929549753.HKD","BK4588","LU1974910355.USD","LU2324357040.USD","LU0266013472.USD","LU1066053197.SGD","IE0004445239.USD","LU2433249047.HKD","LU0211327993.USD","LU0310799852.SGD","LU0708994859.HKD","IE000BZT7R73.USD","SGXZ57979304.SGD","LU0289739343.SGD","LU2491049909.HKD","LU0058720904.USD","IE000MB6IJN5.SGD","LU2237443382.USD","SG9999014542.SGD","LU0203345920.USD","LU0882574055.USD","LU0320765489.SGD","SG9999014567.USD","LU0211328371.USD","LU0265550946.USD","LU0820561909.HKD","IE00B42XCP33.USD","SG9999015952.SGD","SG9999014575.USD","LU1699723380.USD","LU2347655156.SGD","MRK","LU0310800379.SGD","LU1023059063.AUD","LU0980610538.SGD","LU1069347547.HKD","LU1718418525.SGD","LU2112291526.USD","LU1551013425.SGD","LU1934455277.USD","BK4550","LU1941712264.USD","LU1732800096.USD","IE0000B7K699.USD","LU0106261372.USD","LU0553294199.USD","LU0128525929.USD","IE000WAW04H5.SGD","LU0006306889.USD","LU0057025933.USD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197525623","title":"独家：美国议员发函要求获取近十年数百项试验文件，含数据保护流程","url":"https://stock-news.laohu8.com/highlight/detail?id=1197525623","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197525623?lang=zh_cn&edition=full","pubTime":"2026-06-30 18:03","pubTimestamp":1782813780,"startTime":"0","endTime":"0","summary":"美国国会议员已发出信函，要求相关方面提供过去约十年间进行的数百项临床试验的详细文件，其中特别要求包含与患者数据保护流程相关的信息。此举旨在对制药行业的临床试验操作，尤其是数据安全与隐私保护环节，进行更深入的审查与监督。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772840.SGD","LU1074936037.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU0310800379.SGD","LU2089284900.SGD","IE00BJT1NW94.SGD","BK4139","LU0965509101.SGD","LU1974910355.USD","LU2237443978.SGD","LU2361044865.SGD","LU2125909593.SGD","LU1003077747.HKD","LU0738911758.USD","IE000MB6IJN5.SGD","LU2237443622.USD","LU2360032135.SGD","LU0477156953.USD","LU1066051225.USD","IE00BBT3K403.USD","LU1267930573.SGD","LU1923622614.USD","LU0057025933.USD","IE00BFTCPJ56.SGD","LU0122379950.USD","LU0456855351.SGD","BK4007","LU0472753341.HKD","LU2347655156.SGD","SG9999015978.USD","LU0234572021.USD","LU1291159041.SGD","LU1732800096.USD","LU0661504455.SGD","BK4566","SG9999014567.USD","LU1839511570.USD","LU1037948541.HKD","LU0069063385.USD","LU1066051811.HKD","LU2237443895.HKD","SG9999013999.USD","LU1670628061.USD","LU0070302665.USD","LU0795875169.SGD","LU1093756168.USD","LU0114720955.EUR","LU1057294990.SGD","LU2125154778.USD","IE00BN8TJ469.HKD","SG9999001176.USD","LU0238689110.USD","LU1934455194.USD","BK4585","LU1066053197.SGD","BK4588","LU0320765646.SGD","SG9999003800.SGD","LU0942090050.USD","LU0256863811.USD","LU0861579265.USD","LU0203347892.USD","LU0689626769.HKD","LU0029864427.USD","LU0985320562.USD","IE00B4R5TH58.HKD","LU1699723380.USD","LU0417517546.SGD","LU0689472784.USD","LU1732799900.SGD","LU1929549753.HKD","LU0882574055.USD","LU0310799852.SGD","LU2491050154.USD","LU2491050071.SGD","LU0708994859.HKD","LU2089984988.USD","LU1551013425.SGD","LU2089283258.USD","LU0868494708.USD","SG9999015358.SGD","LU0058720904.USD","LU2361044949.HKD","LU0553294199.USD","SG9999001176.SGD","LU1718418525.SGD","IE00BDGV0183.EUR","LU2433249047.HKD","IE000F7OJYX1.SGD","IE00BLSP4239.USD","LU1496350171.SGD","LU0965508806.USD","IE00BGHQF631.EUR","LU2461242641.AUD","LU0265550946.USD","LU0211331839.USD","LU0130102774.USD","LU0170899867.USD","LU0965509010.AUD","LU1551013342.USD","IE0002270589.USD","LU0124676726.USD","LU0912757837.SGD","SG9999015952.SGD","LU0943347566.SGD","IE00BVYPNW00.USD","LU0949170772.SGD","LU0234570918.USD","LU2129689605.HKD","LU2129689431.USD","LU0795875086.SGD","LU2023250843.SGD","LU1430594728.SGD","LU2023250504.SGD","LU1917777945.USD","SG9999015341.SGD","LU2491049909.HKD","BK4581","LU0266013472.USD","LU1941712348.USD","LU2237443465.HKD","IE00B3PB1722.GBP","SG9999015986.USD","IE000WAW04H5.SGD","LU2125154935.USD","LU0648001328.SGD","SG9999014575.USD","LU0980610538.SGD","IE0002141913.USD","LU0965509283.SGD","LU0289739343.SGD","LU2324357040.USD","LU0128525929.USD","SG9999011175.SGD","IE0009355771.USD","IE00B42XCP33.USD","LU1116320901.HKD","LU0158827948.USD","LU1244550577.SGD","LU1670627923.USD","LU1989772923.USD","LU0098860793.USD","IE00B1BXHZ80.USD","LU1496350502.SGD","IE00BLSP4452.SGD","LU0203345920.USD","LU1066051498.USD","IE00BSNM7G36.USD","LU2357627491.SGD","IE000BZT7R73.USD","IE0004445239.USD","LU1037948897.HKD","LU0823416689.USD","LU2125909247.SGD","LU1244550494.USD","LU2087621335.USD","LU1116320737.USD","LU0289961442.SGD","IE00B19Z3581.USD","LU0211327993.USD","IE000SO60NU8.SGD","BK4533","LU2129689514.USD","LU0006306889.USD","IE00B19Z3B42.SGD","LU1201861249.SGD","IE00BVYPNV92.GBP","LU2133065610.SGD","SG9999001440.SGD","ABBV","LU1267930490.SGD","LU2468319806.SGD","LU0208291251.USD","LU0820561909.HKD","LU0511384066.AUD","LU1069347547.HKD","LU1941712264.USD","LU1571399168.USD","LU0256863902.USD","LU1023059063.AUD","IE0000B7K699.USD","BK4534","LU1162221912.USD","LU0289739699.SGD","LU0106261372.USD","LU2023251221.USD","LU1934455277.USD","BK4559","LU0432979614.USD","LU2112291526.USD","IE000M9KFDE8.USD","LU1934455863.HKD","LU2361045086.USD","LU0320765489.SGD","SGXZ57979304.SGD","IE00B2B36J28.USD","LU2106854487.HKD","LU0859254822.USD","LU0820561818.USD","LU0265550359.USD","LU1061106388.HKD","SG9999014559.SGD","LU1035773651.USD","BK4550","SG9999002232.USD","BK4516","LU1989771016.USD","LU1244550221.USD","LU0211328371.USD","LU2237443382.USD","SG9999014542.SGD","LU2237443549.SGD","SG9999002224.SGD","LU1093756325.SGD","LU1585245621.USD","LU0198837287.USD","MRK","LU0130517989.USD","LU0545039389.USD","LU0868494617.USD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110159985","title":"艾伯维宣布Epcoritamab联合来那度胺在复发或难治性弥漫性大B细胞淋巴瘤患者中取得积极三期试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1110159985","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110159985?lang=zh_cn&edition=full","pubTime":"2026-06-30 04:53","pubTimestamp":1782766394,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，其药物Epcoritamab联合来那度胺，在治疗复发或难治性弥漫性大B细胞淋巴瘤患者的三期临床试验中，取得了积极成果。这一关键性研究的正面数据，为这种侵袭性淋巴瘤患者带来了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","LU0708994859.HKD","LU0234572021.USD","BK4559","BK4566","IE00B42XCP33.USD","LU0861579265.USD","LU2347655156.SGD","LU2468319806.SGD","LU1929549753.HKD","IE0009355771.USD","IE00B19Z3B42.SGD","LU1037948541.HKD","IE00BVYPNV92.GBP","LU1061106388.HKD","LU0058720904.USD","IE00BLSP4239.USD","LU0795875086.SGD","LU1162221912.USD","LU0965509010.AUD","LU0545039389.USD","LU0114720955.EUR","IE00B3PB1722.GBP","LU2129689514.USD","LU1983299246.USD","LU2237443622.USD","IE0002270589.USD","LU2237443549.SGD","IE00B19Z3581.USD","BK4585","LU1244550494.USD","BK4533","LU0211328371.USD","IE000F7OJYX1.SGD","LU0128525929.USD","LU0170899867.USD","LU1093756168.USD","LU2089984988.USD","LU2133065610.SGD","IE0004445239.USD","LU0234570918.USD","BK4550","LU0820561909.HKD","LU1670628061.USD","LU0203347892.USD","SG9999015945.SGD","LU1037948897.HKD","LU0124676726.USD","LU0029864427.USD","BK4581","LU0912757837.SGD","LU1551013425.SGD","LU1023059063.AUD","LU0738911758.USD","LU2023251221.USD","LU0985320562.USD","LU0098860793.USD","LU1934455863.HKD","LU0122379950.USD","LU0511384066.AUD","IE00BJJMRZ35.SGD","LU0158827948.USD","LU0456855351.SGD","LU0256863811.USD","LU0689626769.HKD","LU1093756325.SGD","LU2237443978.SGD","IE0002141913.USD","LU0859254822.USD","LU0942090050.USD","LU1732799900.SGD","LU0689472784.USD","LU1291159041.SGD","LU2089284900.SGD","LU1244550577.SGD","IE00BN8TJ469.HKD","LU1267930573.SGD","LU1430594728.SGD","LU0472753341.HKD","LU1732800096.USD","IE0000B7K699.USD","IE00BSNM7G36.USD","IE000BZT7R73.USD","LU0069063385.USD","BK4534","LU1718418525.SGD","LU1057294990.SGD","LU1934455277.USD","LU0310800379.SGD","LU2089283258.USD","LU2129689431.USD","IE000WAW04H5.SGD","LU0553294199.USD","LU0289961442.SGD","LU0965509283.SGD","LU0417517546.SGD","IE00BLSP4452.SGD","LU1003077747.HKD","LU0943347566.SGD","LU1496350502.SGD","IE000SO60NU8.SGD","IE00B2B36J28.USD","LU1267930490.SGD","LU1074936037.SGD","LU0203345920.USD","LU0432979614.USD","BK4588","LU2129689605.HKD","LU0198837287.USD","LU0965508806.USD","IE00BBT3K403.USD","LU0868494708.USD","LU1585245621.USD","LU0661504455.SGD","LU2087621335.USD","SG9999015986.USD","LU0256863902.USD","ABBV","LU1496350171.SGD","LU1670627923.USD","LU0868494617.USD","LU1989771016.USD","LU2237443382.USD","LU0310799852.SGD","LU0965509101.SGD","LU1989772840.SGD","LU2357627491.SGD","LU0882574055.USD","IE00BGHQF631.EUR","SG9999015978.USD","IE00BDGV0183.EUR","LU1839511570.USD","LU1551013342.USD","SG9999015952.SGD","LU0820561818.USD","LU1934455194.USD","SG9999011175.SGD","LU0795875169.SGD","LU1989772923.USD","LU0823416689.USD","SG9999003800.SGD","LU1244550221.USD","IE00BVYPNW00.USD","IE00BFTCPJ56.SGD","BK4139","LU0057025933.USD","LU0289739343.SGD","IE00BJT1NW94.SGD","LU2237443895.HKD","LU0949170772.SGD","IE00B4R5TH58.HKD","LU0211327993.USD","LU0289739699.SGD","SG9999001440.SGD","IE000MB6IJN5.SGD","LU0320765646.SGD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130790553","title":"艾伯维公司Rinvoq®获欧盟CHMP积极意见 用于治疗成人和青少年非节段型白癜风","url":"https://stock-news.laohu8.com/highlight/detail?id=1130790553","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130790553?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:08","pubTimestamp":1782716916,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，其药物Upadacitinib（商品名：Rinvoq®）已获得欧洲药品管理局人用药品委员会（CHMP）的积极评价，该药物拟用于治疗成人和青少年非节段型白癜风患者。这一积极意见标志着该疗法在欧盟监管审批进程中迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989771016.USD","LU0965509283.SGD","LU1839511570.USD","LU0912757837.SGD","LU0689626769.HKD","SG9999003800.SGD","LU0198837287.USD","LU0661504455.SGD","LU0310800379.SGD","IE00B4R5TH58.HKD","BK4588","LU1670628061.USD","IE00BJJMRZ35.SGD","LU1585245621.USD","LU0122379950.USD","LU1430594728.SGD","LU0456855351.SGD","IE00BJT1NW94.SGD","LU0057025933.USD","IE00BDGV0183.EUR","IE0009355771.USD","LU0795875086.SGD","LU1267930573.SGD","LU0234570918.USD","LU1670627923.USD","LU2347655156.SGD","BK4534","LU2129689514.USD","LU2129689431.USD","BK4581","LU2023251221.USD","LU1267930490.SGD","LU0868494708.USD","LU0256863902.USD","LU0553294199.USD","LU1061106388.HKD","LU0069063385.USD","BK4139","LU0545039389.USD","LU1718418525.SGD","LU0211327993.USD","IE00B2B36J28.USD","LU0859254822.USD","IE00B19Z3581.USD","LU2237443465.HKD","LU2237443382.USD","LU1057294990.SGD","LU1551013425.SGD","BK4559","LU2237443622.USD","IE00BLSP4239.USD","BK4550","LU0289739699.SGD","LU1244550221.USD","LU0128525929.USD","LU0965509101.SGD","LU1929549753.HKD","LU1983299246.USD","LU2133065610.SGD","LU0820561909.HKD","LU1093756325.SGD","IE0000B7K699.USD","LU0310799852.SGD","IE00B19Z3B42.SGD","LU0965508806.USD","IE000MB6IJN5.SGD","LU1551013342.USD","IE0004445239.USD","IE00BFTCPJ56.SGD","BK4566","LU1989772923.USD","LU2112291526.USD","LU1003077747.HKD","LU0949170772.SGD","SG9999001440.SGD","LU1244550577.SGD","LU0029864427.USD","LU2089284900.SGD","LU0985320562.USD","LU2357627491.SGD","IE000WAW04H5.SGD","BK4585","LU1934455277.USD","LU1934455863.HKD","LU2089984988.USD","LU0203347892.USD","LU2468319806.SGD","LU2089283258.USD","LU0942090050.USD","LU0689472784.USD","LU0861579265.USD","LU0965509010.AUD","IE00BLSP4452.SGD","LU0417517546.SGD","LU1934455194.USD","LU1291159041.SGD","LU1244550494.USD","SG9999011175.SGD","LU1732799900.SGD","LU0823416689.USD","LU0432979614.USD","SG9999015952.SGD","LU1732800096.USD","LU1037948541.HKD","SG9999015986.USD","IE0002141913.USD","LU0820561818.USD","LU0868494617.USD","LU2237443978.SGD","LU0738911758.USD","LU1023059063.AUD","LU0203345920.USD","IE00BSNM7G36.USD","IE00BBT3K403.USD","LU0289739343.SGD","LU2237443549.SGD","LU1093756168.USD","LU0170899867.USD","LU0098860793.USD","LU0124676726.USD","LU0289961442.SGD","LU0158827948.USD","LU1074936037.SGD","LU2129689605.HKD","LU0256863811.USD","ABBV","LU0114720955.EUR","LU0708994859.HKD","LU1037948897.HKD","LU1989772840.SGD","IE00BGHQF631.EUR","LU0795875169.SGD","LU1496350502.SGD","IE00B42XCP33.USD","LU2087621335.USD","IE00BVYPNV92.GBP","IE000SO60NU8.SGD","LU2237443895.HKD","BK4533","LU0320765646.SGD","LU0882574055.USD","IE000BZT7R73.USD","IE00BN8TJ469.HKD","LU0058720904.USD","IE000F7OJYX1.SGD","LU1162221912.USD","LU0472753341.HKD","LU0234572021.USD","IE00BVYPNW00.USD","LU0943347566.SGD","SG9999015945.SGD","LU0211328371.USD","LU0511384066.AUD","IE0002270589.USD","IE00B3PB1722.GBP","LU1496350171.SGD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143206979","title":"一周美股牛榜 | Bio-Techne上周飙涨逾22%，艾伯维公司劲升逾17%，联合大陆航空涨超15%，康宁涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143206979","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143206979?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:18","pubTimestamp":1782699520,"startTime":"0","endTime":"0","summary":"默克提出每股73美元的收购要约后，Bio-Techne股价本周上涨22.5%，较该公司周三收盘价溢价24%。艾伯维斥资109亿美元收购Apogee，强化免疫学领域战略艾伯维股价本周上涨17%。联合大陆航空股价上涨，油价下跌和分析师看涨情绪提振航空股本周，联合大陆航空股价上涨15%。为了进一步提升股东价值，康宁董事会宣布派发每股0.28美元的季度股息。股息将于9月29日支付给截至8月31日登记在册的股东。","market":"us","thumbnail":"https://static.tigerbbs.com/98882962e3042a24d8295da8457c9db5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/98882962e3042a24d8295da8457c9db5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLW","INCY","UAL","ABBV","CRL","TECH","GLWG","IQV","RVTY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1187753194","title":"异动解读｜艾伯维公司盘中上涨3.31%，109亿美元收购Apogee叠加多重产品获批持续提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1187753194","media":"行情直击","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187753194?lang=zh_cn&edition=full","pubTime":"2026-06-27 03:56","pubTimestamp":1782503815,"startTime":"0","endTime":"0","summary":"6月26日，艾伯维公司盘中上涨3.31%，报251.23美元/股，成交额22.61亿美元。消息面上，公司近日宣布以约109亿美元全现金收购Apogee Therapeutics，获取核心资产zumilokibart，UBS认为该交易估值\"充分合理\"，该药在特应性皮炎及哮喘领域具备\"超级重磅炸弹潜力\"。同时，Canaccord Genuity将目标价上调至273美元，Rothschild & Co Redburn上调至284美元，均维持买入评级。产品端，Skyrizi获欧盟批准扩展至儿童银屑病，Maviret获批用于急性丙肝，多重利好共振持续推升股价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199295327","title":"异动解读｜艾伯维公司盘中上涨3.23%，109亿美元收购Apogee持续提振叠加多重利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1199295327","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199295327?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:49","pubTimestamp":1782398942,"startTime":"0","endTime":"0","summary":"6月25日，艾伯维公司盘中上涨3.23%，报242.47美元/股，成交额3.75亿美元。消息面上，艾伯维近日宣布以约109亿美元全现金收购Apogee Therapeutics，获取其核心资产zumilokibart，强化免疫学管线布局。Canaccord Genuity随后将艾伯维目标价从265美元上调至273美元，维持买入评级。此外，艾伯维旗下Skyrizi获欧盟批准用于儿童银屑病、Maviret获批用于急性丙肝治疗，旗下艾尔建美学新品Boey在加拿大获批，多重产品线利好共同提振市场信心。交易预计三季度完成，反垄断风险有限。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136601431","title":"医美巨头证实“司美格鲁肽脸”真实存在 新上市再生医美公司欲入局分羹","url":"https://stock-news.laohu8.com/highlight/detail?id=1136601431","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136601431?lang=zh_cn&edition=full","pubTime":"2026-06-25 21:06","pubTimestamp":1782392808,"startTime":"0","endTime":"0","summary":"医美行业巨头们已证实，由GLP-1减肥药引发的面部脂肪流失现象——“司美格鲁肽脸”——是真实存在的副作用。这一市场新动态，正为专注于再生医学的医美公司开辟出全新的竞争赛道。一家新近上市的再生医学领域参与者，已明确表示将瞄准这一快速增长的需求。市场分析指出，“司美格鲁肽脸”现象催生的不仅是新的治疗需求，更是一个潜在的交叉增长市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772923.USD","LU1496350502.SGD","LU1989772840.SGD","LU1732799900.SGD","LU0289739343.SGD","LU0912757837.SGD","LU0823416689.USD","BK4585","LU0859254822.USD","LU0965509010.AUD","LU2089984988.USD","SG9999003800.SGD","LU2237443895.HKD","LU2089283258.USD","SG9999001440.SGD","LU0820561909.HKD","LU0170899867.USD","LU0234572021.USD","LU0432979614.USD","LU1037948897.HKD","LU1430594728.SGD","LU2237443549.SGD","IE00BBT3K403.USD","LU1732800096.USD","LU0256863902.USD","IE00B19Z3581.USD","IE0000B7K699.USD","LU1983299246.USD","LU1037948541.HKD","BK4588","IE00B3PB1722.GBP","LU0553294199.USD","LU0203347892.USD","IE0002141913.USD","IE00BDGV0183.EUR","LU2237443382.USD","LU0965508806.USD","BK4082","BK4581","IE00BLSP4239.USD","LU2347655156.SGD","LU2089284900.SGD","LU1989771016.USD","LU0289961442.SGD","LU1496350171.SGD","LU0203345920.USD","IE00B4R5TH58.HKD","LU0689472784.USD","IE00B19Z3B42.SGD","LU0058720904.USD","LU1074936037.SGD","IE00BGHQF631.EUR","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0310800379.SGD","LU1057294990.SGD","BK4533","IE0009355771.USD","LU1093756325.SGD","IE00B2B36J28.USD","LU0256863811.USD","LU0320765646.SGD","LU1839511570.USD","LU1934455863.HKD","LU1670627923.USD","IE000MB6IJN5.SGD","IE000WAW04H5.SGD","LU0069063385.USD","LU1162221912.USD","LU0211328371.USD","LU1718418525.SGD","LU0965509101.SGD","IE00BLSP4452.SGD","LU0417517546.SGD","ESTA","LU0029864427.USD","LU1934455194.USD","BK4198","LU2023251221.USD","LU0965509283.SGD","LU0511384066.AUD","LU0795875086.SGD","LU0820561818.USD","LU1934455277.USD","LU0738911758.USD","IE00BJT1NW94.SGD","LU1093756168.USD","LU1585245621.USD","LU0868494708.USD","LU0158827948.USD","IE0002270589.USD","LU1929549753.HKD","IE00BN8TJ469.HKD","LU0545039389.USD","SG9999015952.SGD","LU2237443465.HKD","LU0456855351.SGD","IE000BZT7R73.USD","LU0661504455.SGD","LU1291159041.SGD","LU0985320562.USD","LU1670628061.USD","BK4139","LU2129689605.HKD","LU1551013342.USD","LU1267930573.SGD","LU2129689514.USD","IE00BSNM7G36.USD","INMD","ABBV","LU0211327993.USD","LU1023059063.AUD","LU1003077747.HKD","BK4559","LU0861579265.USD","LU0708994859.HKD","LU2237443622.USD","LU2133065610.SGD","SG9999015945.SGD","LU0114720955.EUR","SG9999015978.USD","SG9999015986.USD","BK4566","IE00BVYPNV92.GBP","LU1551013425.SGD","CNXU","LU0689626769.HKD","LU2468319806.SGD","IE00BVYPNW00.USD","LU0128525929.USD","LU0098860793.USD","LU0949170772.SGD","LU0868494617.USD","IE00B42XCP33.USD","LU0124676726.USD","BK4550","LU0289739699.SGD","LU0310799852.SGD","LU0122379950.USD","IE0004445239.USD","LU0234570918.USD","LU2237443978.SGD","LU0882574055.USD","BK4534","LU0795875169.SGD","LU1267930490.SGD","LU1061106388.HKD","LU2357627491.SGD","LU1244550221.USD","LU0943347566.SGD","LU0198837287.USD","LU0942090050.USD","IE000F7OJYX1.SGD","IE00BJJMRZ35.SGD","LU1244550577.SGD","LU2324357040.USD","LU1244550494.USD","LU0472753341.HKD","SG9999011175.SGD","LU2129689431.USD","LU0057025933.USD","IE000SO60NU8.SGD","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117059267","title":"艾伯维-爱力根美学部门将启动培训，为未来数月内Boey的商业上市做准备","url":"https://stock-news.laohu8.com/highlight/detail?id=1117059267","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117059267?lang=zh_cn&edition=full","pubTime":"2026-06-23 20:02","pubTimestamp":1782216166,"startTime":"0","endTime":"0","summary":"艾伯维公司旗下的爱力根美学部门即将启动相关培训工作，并为新产品Boey在未来几个月内的商业上市进行筹备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000BZT7R73.USD","LU0545039389.USD","LU1551013342.USD","SG9999003800.SGD","LU1934455863.HKD","IE0002270589.USD","IE0004445239.USD","IE00B2B36J28.USD","LU0965509010.AUD","IE00BLSP4452.SGD","LU0057025933.USD","LU0985320562.USD","LU2237443549.SGD","LU0211328371.USD","LU0795875086.SGD","LU2237443465.HKD","LU0310800379.SGD","IE00B3PB1722.GBP","LU0511384066.AUD","LU2129689605.HKD","LU0198837287.USD","LU2347655156.SGD","LU0289961442.SGD","LU1989772840.SGD","IE00B19Z3581.USD","LU1551013425.SGD","LU1718418525.SGD","LU0912757837.SGD","LU0868494617.USD","LU1057294990.SGD","LU0122379950.USD","LU1732800096.USD","LU0689472784.USD","IE0000B7K699.USD","LU1291159041.SGD","LU2237443978.SGD","LU2089284900.SGD","IE00BBT3K403.USD","LU1244550221.USD","LU1732799900.SGD","LU1074936037.SGD","LU0234572021.USD","IE00B4R5TH58.HKD","LU0203347892.USD","IE00BJT1NW94.SGD","BK4566","LU0098860793.USD","SG9999015986.USD","LU1061106388.HKD","LU0942090050.USD","IE000SO60NU8.SGD","LU0859254822.USD","SG9999001440.SGD","LU0114720955.EUR","LU1267930490.SGD","LU1934455277.USD","LU1585245621.USD","IE00BN8TJ469.HKD","LU0158827948.USD","LU0820561909.HKD","IE00BVYPNW00.USD","LU0553294199.USD","LU1023059063.AUD","BK4534","LU0289739699.SGD","BK4533","LU2089984988.USD","BK4559","IE00B19Z3B42.SGD","LU0949170772.SGD","SG9999015945.SGD","LU1037948897.HKD","IE00BDGV0183.EUR","IE000WAW04H5.SGD","LU0029864427.USD","LU1162221912.USD","BK4139","LU0058720904.USD","LU1989772923.USD","LU1267930573.SGD","LU0289739343.SGD","IE0009355771.USD","LU0310799852.SGD","LU2129689431.USD","LU0432979614.USD","LU0069063385.USD","LU0795875169.SGD","LU1670628061.USD","LU2129689514.USD","LU2237443622.USD","LU1496350171.SGD","ABBV","LU0965508806.USD","LU1003077747.HKD","LU1037948541.HKD","LU0820561818.USD","LU0256863902.USD","LU1670627923.USD","LU1934455194.USD","LU2237443382.USD","LU1929549753.HKD","LU0124676726.USD","IE0002141913.USD","IE000F7OJYX1.SGD","LU0689626769.HKD","IE00B42XCP33.USD","LU0965509101.SGD","BK4588","SG9999011175.SGD","IE00BLSP4239.USD","LU0708994859.HKD","LU0170899867.USD","LU0472753341.HKD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU0234570918.USD","LU1093756325.SGD","LU2237443895.HKD","LU1989771016.USD","LU0738911758.USD","BK4585","LU2087621335.USD","SG9999015952.SGD","LU2112291526.USD","IE000MB6IJN5.SGD","LU0456855351.SGD","LU1093756168.USD","LU0823416689.USD","LU1244550577.SGD","LU0861579265.USD","LU0882574055.USD","LU2357627491.SGD","LU0211327993.USD","LU0203345920.USD","IE00BGHQF631.EUR","LU0417517546.SGD","BK4550","IE00BFTCPJ56.SGD","LU0943347566.SGD","LU0965509283.SGD","LU2089283258.USD","LU1430594728.SGD","LU2023251221.USD","IE00BVYPNV92.GBP","LU0661504455.SGD","LU0256863811.USD","IE00BSNM7G36.USD","LU2468319806.SGD","LU2133065610.SGD","LU0320765646.SGD","LU0868494708.USD","BK4581","SG9999015978.USD","LU0128525929.USD","LU1244550494.USD","LU1496350502.SGD","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143485673","title":"艾伯维宣布Maviret®获欧盟批准用于治疗急性丙型肝炎病毒感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1143485673","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143485673?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:00","pubTimestamp":1782205239,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，其药物Maviret®（格卡瑞韦/哌仑他韦）已获得欧洲委员会的批准，用于治疗急性丙型肝炎病毒感染患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739343.SGD","LU0069063385.USD","LU2347655156.SGD","IE000BZT7R73.USD","LU2129689514.USD","LU1057294990.SGD","LU1244550494.USD","SG9999003800.SGD","LU0124676726.USD","BK4139","LU2357627491.SGD","LU1670628061.USD","LU1074936037.SGD","LU0158827948.USD","LU0310799852.SGD","LU0943347566.SGD","LU0823416689.USD","IE00BFTCPJ56.SGD","BK4550","LU0057025933.USD","SG9999015986.USD","LU0128525929.USD","IE000WAW04H5.SGD","LU0198837287.USD","LU0820561909.HKD","SG9999015978.USD","LU0098860793.USD","LU0029864427.USD","LU0949170772.SGD","LU0820561818.USD","LU2089984988.USD","LU1291159041.SGD","LU2468319806.SGD","LU0965509283.SGD","SG9999001440.SGD","LU0861579265.USD","LU0170899867.USD","BK4585","LU2237443895.HKD","LU0738911758.USD","LU0661504455.SGD","IE00BDGV0183.EUR","LU0912757837.SGD","LU2089283258.USD","IE0002141913.USD","LU1934455863.HKD","LU0320765646.SGD","LU1244550221.USD","LU2237443382.USD","LU0417517546.SGD","LU1093756325.SGD","LU0289739699.SGD","LU1023059063.AUD","LU0511384066.AUD","LU1244550577.SGD","LU1670627923.USD","SG9999015952.SGD","BK4534","LU1162221912.USD","IE00B3PB1722.GBP","LU0256863902.USD","LU1989771016.USD","IE00B4R5TH58.HKD","BK4533","LU1061106388.HKD","BK4588","LU0122379950.USD","IE0002270589.USD","IE00BN8TJ469.HKD","LU1934455277.USD","LU0965509010.AUD","LU0203347892.USD","IE00BJT1NW94.SGD","LU1989772923.USD","LU0965508806.USD","LU0114720955.EUR","LU0432979614.USD","LU0965509101.SGD","LU2237443622.USD","IE00BVYPNV92.GBP","IE00BSNM7G36.USD","LU1267930490.SGD","LU1718418525.SGD","LU1983299246.USD","LU0553294199.USD","SG9999011175.SGD","BK4566","LU0545039389.USD","LU2237443549.SGD","IE0009355771.USD","LU1551013342.USD","LU0211327993.USD","LU1732800096.USD","IE00BVYPNW00.USD","LU0795875169.SGD","LU0689472784.USD","IE000SO60NU8.SGD","ABBV","LU0985320562.USD","LU0203345920.USD","LU0689626769.HKD","LU0868494708.USD","LU1496350502.SGD","LU1989772840.SGD","LU2133065610.SGD","LU0256863811.USD","SG9999015945.SGD","LU0942090050.USD","LU0211328371.USD","LU2237443978.SGD","LU0234570918.USD","LU1732799900.SGD","LU0456855351.SGD","LU2023251221.USD","LU1839511570.USD","LU0868494617.USD","IE0000B7K699.USD","IE00B2B36J28.USD","LU2129689605.HKD","IE00BLSP4452.SGD","LU2087621335.USD","IE00B42XCP33.USD","IE00BGHQF631.EUR","LU1496350171.SGD","LU1037948541.HKD","LU1430594728.SGD","IE0004445239.USD","LU0708994859.HKD","LU1093756168.USD","LU0310800379.SGD","IE000F7OJYX1.SGD","LU2112291526.USD","LU1585245621.USD","IE00B19Z3581.USD","LU1037948897.HKD","LU2089284900.SGD","LU0795875086.SGD","IE00BLSP4239.USD","LU0058720904.USD","LU0882574055.USD","IE00BBT3K403.USD","IE00BJJMRZ35.SGD","LU2129689431.USD","LU1934455194.USD","LU1003077747.HKD","LU2237443465.HKD","IE00B19Z3B42.SGD","LU0289961442.SGD","BK4559","LU0472753341.HKD","LU0859254822.USD","LU1551013425.SGD","LU1929549753.HKD","IE000MB6IJN5.SGD","BK4581","LU1267930573.SGD","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645888902","title":"艾伯维(ABBV)免疫产品SKYRIZI获欧盟批准 扩展至儿童与青少年中重度斑块状银屑病范畴","url":"https://stock-news.laohu8.com/highlight/detail?id=2645888902","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645888902?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:28","pubTimestamp":1782203332,"startTime":"0","endTime":"0","summary":"该药现可用于治疗6岁及以上、适合接受系统治疗的中重度斑块状银屑病儿童和青少年患者。临床数据显示，在入组的137名儿童及青少年患者中，SKYRIZI展现出的安全性特征与此前在成年患者中观察到的高度一致，未发现任何新的安全信号。艾伯维高级副总裁兼首席科学官Roopal Thakkar博士表示，儿童斑块状银屑病具有极高的临床复杂性。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/YTM1NDI1NzQzMjY4NQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YTM1NDI1NzQzMjY4NQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301776","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965508806.USD","IE00BFTCPJ56.SGD","LU0417517546.SGD","IE0009355771.USD","LU1496350171.SGD","LU2133065610.SGD","LU0795875086.SGD","IE00BLSP4239.USD","BK4534","IE000BZT7R73.USD","LU0234570918.USD","FESXmain","LU0882574055.USD","LU1057294990.SGD","LU2112291526.USD","LU2237443549.SGD","LU0912757837.SGD","IE00BVYPNV92.GBP","LU0320765646.SGD","LU1934455277.USD","LU2468319806.SGD","SG9999011175.SGD","IE00B2B36J28.USD","LU1929549753.HKD","LU1162221912.USD","LU0738911758.USD","IE00B19Z3B42.SGD","LU0942090050.USD","LU0949170772.SGD","LU0868494617.USD","FSXEmain","LU0472753341.HKD","IE00BLSP4452.SGD","LU0511384066.AUD","LU0057025933.USD","LU1291159041.SGD","LU2089284900.SGD","BK4550","SG9999015945.SGD","BK4533","SG9999001440.SGD","LU1989771016.USD","LU1244550221.USD","LU2237443382.USD","IE00BGHQF631.EUR","LU0203345920.USD","LU1244550494.USD","ABBV","LU2089283258.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130332746","title":"艾伯维公司宣布欧盟委员会批准Skyrizi®（瑞莎珠单抗）用于治疗中重度斑块状银屑病儿科患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1130332746","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130332746?lang=zh_cn&edition=full","pubTime":"2026-06-23 15:00","pubTimestamp":1782198018,"startTime":"0","endTime":"0","summary":"艾伯维公司宣布，其药物Skyrizi®（通用名：瑞莎珠单抗）已获得欧盟委员会的批准，用于治疗中重度斑块状银屑病的儿科患者。这一监管批准为患有该慢性皮肤疾病的儿童和青少年提供了一个新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","IE00BDGV0183.EUR","SG9999015986.USD","LU2089283258.USD","LU2357627491.SGD","BK4533","IE0009355771.USD","LU2133065610.SGD","LU0868494708.USD","LU1551013342.USD","IE0000B7K699.USD","LU0882574055.USD","LU0456855351.SGD","LU0823416689.USD","BK4559","LU0122379950.USD","LU0689626769.HKD","IE00B42XCP33.USD","LU2468319806.SGD","LU1061106388.HKD","IE000F7OJYX1.SGD","LU1732800096.USD","LU0868494617.USD","LU0795875169.SGD","LU0553294199.USD","LU0708994859.HKD","LU2237443465.HKD","LU0289739699.SGD","LU0128525929.USD","LU0689472784.USD","LU0545039389.USD","LU2347655156.SGD","LU1037948897.HKD","IE00BGHQF631.EUR","LU1074936037.SGD","LU0511384066.AUD","BK4581","IE0004445239.USD","LU0203347892.USD","LU0820561818.USD","IE00B3PB1722.GBP","LU0198837287.USD","LU0942090050.USD","LU0211327993.USD","LU0211328371.USD","LU1670628061.USD","LU1057294990.SGD","LU1267930573.SGD","IE00BBT3K403.USD","ABBV","LU0310799852.SGD","BK4139","SG9999015952.SGD","SG9999001440.SGD","LU0069063385.USD","LU2129689514.USD","IE00B4R5TH58.HKD","LU2237443549.SGD","LU0912757837.SGD","IE00BSNM7G36.USD","IE000WAW04H5.SGD","BK4585","LU1496350502.SGD","LU1718418525.SGD","LU0289961442.SGD","SG9999003800.SGD","LU0310800379.SGD","LU0859254822.USD","LU0234572021.USD","LU0058720904.USD","LU0661504455.SGD","LU0203345920.USD","IE0002141913.USD","IE0002270589.USD","LU1430594728.SGD","LU1585245621.USD","LU0057025933.USD","SG9999015945.SGD","LU0472753341.HKD","BK4566","LU2129689605.HKD","LU1093756325.SGD","LU0098860793.USD","LU0158827948.USD","LU2089984988.USD","LU0432979614.USD","IE00B19Z3581.USD","LU0417517546.SGD","LU1244550577.SGD","LU1989771016.USD","IE00BN8TJ469.HKD","LU1267930490.SGD","IE00B19Z3B42.SGD","LU0965509283.SGD","BK4588","LU0949170772.SGD","LU2237443382.USD","LU1934455277.USD","LU0124676726.USD","LU0943347566.SGD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0985320562.USD","LU1934455194.USD","LU1670627923.USD","LU0029864427.USD","LU0234570918.USD","LU2023251221.USD","LU0965508806.USD","IE00BJJMRZ35.SGD","IE000MB6IJN5.SGD","LU1983299246.USD","LU0795875086.SGD","SG9999011175.SGD","IE00BLSP4452.SGD","IE00BLSP4239.USD","SG9999015978.USD","LU1934455863.HKD","IE000BZT7R73.USD","LU1989772840.SGD","LU2237443978.SGD","IE00BVYPNW00.USD","LU1989772923.USD","LU1244550221.USD","LU2237443895.HKD","LU0256863902.USD","LU1839511570.USD","LU1291159041.SGD","LU0820561909.HKD","LU1037948541.HKD","LU0289739343.SGD","LU0965509010.AUD","LU0114720955.EUR","LU1003077747.HKD","LU1093756168.USD","LU0738911758.USD","IE00B2B36J28.USD","LU0170899867.USD","LU1162221912.USD","LU1244550494.USD","LU0965509101.SGD","LU2237443622.USD","BK4550","LU1496350171.SGD","LU0256863811.USD","LU1732799900.SGD","IE000SO60NU8.SGD","LU0861579265.USD","LU2089284900.SGD","LU1023059063.AUD","LU1551013425.SGD","LU2129689431.USD","IE00BVYPNV92.GBP","LU2087621335.USD","LU2112291526.USD","LU1929549753.HKD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146210826","title":"AbbVie以109亿美元收购Apogee Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=1146210826","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146210826?lang=zh_cn&edition=full","pubTime":"2026-06-23 08:57","pubTimestamp":1782176244,"startTime":"0","endTime":"0","summary":"AbbVie同意以约10.9 billion美元全现金收购Apogee Therapeutics，以加强其免疫学产品组合，并加快其在呼吸领域的临床布局。双方于周一联合声明表示，AbbVie将以每股135.11美元现金收购Apogee。Apogee股价于周一交易时段飙升约47%，AbbVie则升3.7%。是次交易将使AbbVie取得Apogee处于临床阶段、用于治疗炎症及免疫疾病的研发产品组合。AbbVie行政总裁Robert Michael于声明中表示，收购Apogee进一步巩固公司现有领导地位，并强化向患者提供创新药物的能力，同时为股东创造长期价值。","market":"us","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"AbbVie以109亿美元收购Apogee Therapeutics","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645078578","title":"109亿美元豪赌下一代“药王”！艾伯维溢价49%收购Apogee，剑指赛诺菲Dupixent","url":"https://stock-news.laohu8.com/highlight/detail?id=2645078578","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645078578?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:05","pubTimestamp":1782137159,"startTime":"0","endTime":"0","summary":"根据协议条款，艾伯维将以每股135.11美元的现金价格收购Apogee所有已发行普通股，总股权价值约为109亿美元。艾伯维预计，2026年Skyrizi销售额约为216亿美元，Rinvoq约为102亿美元，两款药物合计将贡献超过310亿美元的年收入，目前已合计占艾伯维季度总营收的约44%。艾伯维方面则表示，Apogee的管线资产具有“重磅炸弹级别的集体峰值销售潜力”。艾伯维计划通过债务融资来完成此次收购。艾伯维以109亿美元收购Apogee，本质上是一场关于时间差的博弈。","market":"sh","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457208.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"109亿美元豪赌下一代“药王”！艾伯维溢价49%收购Apogee，剑指赛诺菲Dupixent","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B3PB1722.GBP","LU0310799852.SGD","LU2468319806.SGD","IE000F7OJYX1.SGD","LU1983299246.USD","LU0942090050.USD","LU2087621335.USD","LU0058720904.USD","APGE","LU2357627491.SGD","LU0795875086.SGD","LU1430594728.SGD","LU0170899867.USD","LU1244550494.USD","LU0985320562.USD","LU0320765646.SGD","BK4550","LU0203347892.USD","IE0009355771.USD","LU0069063385.USD","LU1934455277.USD","LU0965509101.SGD","LU0820561818.USD","LU0965509010.AUD","LU0098860793.USD","ABBV","LU0912757837.SGD","LU0158827948.USD","IE00BVYPNV92.GBP","LU1057294990.SGD","IE0002141913.USD","LU0545039389.USD","LU0198837287.USD","LU2089283258.USD","SG9999011175.SGD","BK4533","LU0882574055.USD","LU0203345920.USD","LU1003077747.HKD","LU0823416689.USD","IE000MB6IJN5.SGD","LU1061106388.HKD","LU1989772923.USD","LU0820561909.HKD","LU0943347566.SGD","BK4559","LU0029864427.USD","BK4566","LU0511384066.AUD","LU0472753341.HKD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1165474336","title":"异动解读｜艾伯维盘中上涨3.24%，拟109亿美元收购Apogee强化免疫学管线","url":"https://stock-news.laohu8.com/highlight/detail?id=1165474336","media":"行情直击","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165474336?lang=zh_cn&edition=full","pubTime":"2026-06-22 21:42","pubTimestamp":1782135771,"startTime":"0","endTime":"0","summary":"6月22日，艾伯维盘中上涨3.24%，报226.555美元/股，成交额1.97亿美元。消息面上，艾伯维正式宣布以每股135.11美元全现金收购抗炎药物研发商Apogee Therapeutics，总股权价值约109亿美元，较Apogee此前收盘价溢价约60%。这是艾伯维五年多来规模最大的收购。此次收购将把Apogee核心候选药物zumilokibart纳入艾伯维免疫学产品线。该产品线由修美乐、喜达诺和林沃克领衔，去年合计创收304亿美元，同比增长约14%。市场对交易反应积极，Apogee盘前大涨近47%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146349619","title":"艾伯维CEO称Apogee收购是“绝佳契合”，符合构建产品管线及为2030年代以后增添新增长动力的战略","url":"https://stock-news.laohu8.com/highlight/detail?id=1146349619","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146349619?lang=zh_cn&edition=full","pubTime":"2026-06-22 21:07","pubTimestamp":1782133664,"startTime":"0","endTime":"0","summary":"艾伯维首席执行官表示，对Apogee的收购交易与公司战略“绝佳契合”。该战略旨在构建强大的产品管线，并为2030年代及更远的未来增添新的增长驱动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU0965509010.AUD","LU1023059063.AUD","ABBV","LU0472753341.HKD","LU1430594728.SGD","IE00BSNM7G36.USD","LU2237443895.HKD","LU1244550577.SGD","LU1551013342.USD","LU1551013425.SGD","LU1244550221.USD","LU0211327993.USD","LU2129689605.HKD","LU0234572021.USD","SG9999003800.SGD","BK4139","LU2357627491.SGD","LU1732800096.USD","SG9999015978.USD","IE000WAW04H5.SGD","LU1267930573.SGD","SG9999015986.USD","LU0128525929.USD","LU0820561909.HKD","LU1003077747.HKD","LU2089984988.USD","LU0545039389.USD","LU0417517546.SGD","LU0985320562.USD","LU0689626769.HKD","LU0859254822.USD","IE000SO60NU8.SGD","LU0057025933.USD","LU0795875086.SGD","LU1037948897.HKD","LU2133065610.SGD","LU0689472784.USD","IE00B3PB1722.GBP","LU0310799852.SGD","BK4534","LU2237443465.HKD","IE0004445239.USD","IE00B42XCP33.USD","LU0029864427.USD","LU0965508806.USD","LU0965509101.SGD","LU1989772840.SGD","LU1839511570.USD","LU1989771016.USD","BK4550","LU1934455194.USD","BK4566","LU0170899867.USD","LU0432979614.USD","LU0098860793.USD","LU0511384066.AUD","LU0124676726.USD","LU1162221912.USD","LU1934455277.USD","LU2468319806.SGD","LU0861579265.USD","LU0795875169.SGD","LU0198837287.USD","LU1718418525.SGD","LU0158827948.USD","IE00BJT1NW94.SGD","LU1732799900.SGD","LU2129689431.USD","SG9999015952.SGD","LU2089283258.USD","LU0310800379.SGD","LU1934455863.HKD","LU1037948541.HKD","IE0009355771.USD","LU0203347892.USD","LU0114720955.EUR","LU1585245621.USD","LU0868494617.USD","LU0738911758.USD","IE00BVYPNV92.GBP","LU0553294199.USD","LU0965509283.SGD","LU2087621335.USD","LU2237443622.USD","LU2023251221.USD","IE00BBT3K403.USD","LU0289739343.SGD","LU1929549753.HKD","LU2237443382.USD","LU0203345920.USD","LU0820561818.USD","IE000BZT7R73.USD","IE00BN8TJ469.HKD","LU1989772923.USD","IE0002270589.USD","IE00B2B36J28.USD","LU0823416689.USD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4585","BK4588","LU1093756325.SGD","BK4559","LU0289739699.SGD","LU1670627923.USD","LU2237443549.SGD","SG9999011175.SGD","LU0456855351.SGD","LU0211328371.USD","IE00BVYPNW00.USD","LU2112291526.USD","LU0234570918.USD","LU1074936037.SGD","SG9999001440.SGD","LU0882574055.USD","LU0868494708.USD","IE00BLSP4452.SGD","LU0069063385.USD","IE00BLSP4239.USD","LU0256863811.USD","SG9999015945.SGD","BK4581","IE00BGHQF631.EUR","LU0943347566.SGD","LU2089284900.SGD","LU0058720904.USD","LU0912757837.SGD","LU1057294990.SGD","LU2237443978.SGD","LU1496350171.SGD","LU2129689514.USD","LU0256863902.USD","LU0320765646.SGD","IE00BJJMRZ35.SGD","IE00BDGV0183.EUR","IE00BFTCPJ56.SGD","LU0942090050.USD","IE0000B7K699.USD","LU1267930490.SGD","LU1983299246.USD","LU1670628061.USD","IE000F7OJYX1.SGD","LU0661504455.SGD","LU1061106388.HKD","LU1496350502.SGD","IE00B19Z3581.USD","LU1244550494.USD","LU1093756168.USD","LU2347655156.SGD","IE000MB6IJN5.SGD","IE00B4R5TH58.HKD","LU0289961442.SGD","BK4533","LU1291159041.SGD","LU0949170772.SGD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645943014","title":"溢价高达60%！艾伯维拟109亿美元收购Apogee，最快今日官宣","url":"https://stock-news.laohu8.com/highlight/detail?id=2645943014","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645943014?lang=zh_cn&edition=full","pubTime":"2026-06-22 08:30","pubTimestamp":1782088205,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据知情人士透露，艾伯维正接近达成一项斥资近 110 亿美元收购抗炎药物研发商 Apogee Therapeutics的协议。这笔交易预计将成为这家制药巨头自 2019 年以来规模最大的补强式收购。知情人士称，根据正在讨论的收购条款，Apogee的投资者将获得 109 亿美元的现金，这意味着较该公司最近的收盘价有约 60% 的溢价。一笔潜在的交易将进一步增强艾伯维的免疫学产品线。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456676.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1291159041.SGD","APGE","IE0002270589.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","LU1718418525.SGD","LU0289961442.SGD","LU1732799900.SGD","ABBV","IE000SO60NU8.SGD","LU2468319806.SGD","LU2133065610.SGD","LU0689472784.USD","LU1551013425.SGD","LU1929549753.HKD","LU0511384066.AUD","LU2089984988.USD","LU1670628061.USD","BK4533","LU1496350502.SGD","LU1989772840.SGD","LU0310799852.SGD","IE00BVYPNV92.GBP","LU0689626769.HKD","LU0943347566.SGD","IE00B19Z3B42.SGD","LU0861579265.USD","IE0009355771.USD","IE00B4R5TH58.HKD","BK4585","LU1670627923.USD","BK4534","LU0203345920.USD","LU0661504455.SGD","LU2237443465.HKD","LU2237443895.HKD","LU1162221912.USD","LU2112291526.USD","BK4550","IE00BJT1NW94.SGD","LU1989772923.USD","LU0738911758.USD","LU0029864427.USD","IE00BBT3K403.USD","LU1267930490.SGD","LU1585245621.USD","LU1244550577.SGD","LU0942090050.USD","LU0545039389.USD","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153818649","title":"据《金融时报》报道，根据正在讨论的协议条款，艾伯维将以109亿美元现金收购Apogee股东股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1153818649","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153818649?lang=zh_cn&edition=full","pubTime":"2026-06-19 22:18","pubTimestamp":1781878704,"startTime":"0","endTime":"0","summary":"据《金融时报》披露，一项正在磋商中的交易条款显示，制药巨头艾伯维公司（AbbVie）拟以总计109亿美元的现金，收购生物科技公司Apogee Therapeutics的股东股权。此举若最终落地，将标志着艾伯维在其核心免疫学领域之外，进一步强化其在创新生物制剂领域的布局。市场分析人士指出，这笔潜在的巨额交易凸显了大型制药企业对于拥有前景管线的生物技术公司的强烈收购意愿，旨在补充自身产品线并驱动未来增长。目前，双方尚未就交易细节发表正式评论，后续进展值得密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1496350502.SGD","LU1496350171.SGD","LU0868494617.USD","BK4534","LU1670627923.USD","LU1551013342.USD","IE0002141913.USD","LU0057025933.USD","LU0820561909.HKD","LU0882574055.USD","LU1983299246.USD","LU0861579265.USD","IE00BSNM7G36.USD","LU0689626769.HKD","LU0122379950.USD","SG9999015986.USD","LU0310800379.SGD","BK4588","LU0198837287.USD","IE00B19Z3581.USD","BK4566","LU0069063385.USD","LU2023251221.USD","LU0211327993.USD","LU0170899867.USD","IE00BLSP4239.USD","LU2129689431.USD","IE00BBT3K403.USD","LU1989772840.SGD","LU0289739343.SGD","LU2133065610.SGD","IE00BVYPNV92.GBP","SG9999003800.SGD","LU1989772923.USD","IE00BVYPNW00.USD","LU1093756325.SGD","LU1934455863.HKD","IE000BZT7R73.USD","LU0289961442.SGD","LU1244550577.SGD","ABBV","IE00BN8TJ469.HKD","IE00BDGV0183.EUR","IE00BJJMRZ35.SGD","LU0545039389.USD","LU0965508806.USD","IE00BGHQF631.EUR","LU0234572021.USD","IE00B4R5TH58.HKD","LU1037948541.HKD","SG9999015945.SGD","LU1929549753.HKD","LU2237443465.HKD","LU0029864427.USD","LU0320765646.SGD","BK4559","BK4585","LU0289739699.SGD","LU1585245621.USD","LU2237443382.USD","IE0002270589.USD","LU0058720904.USD","LU0128525929.USD","LU0823416689.USD","IE000MB6IJN5.SGD","LU1162221912.USD","LU0472753341.HKD","LU2237443622.USD","SG9999015952.SGD","LU2089284900.SGD","LU0203345920.USD","LU0689472784.USD","LU1732800096.USD","LU1839511570.USD","LU1934455194.USD","SG9999001440.SGD","LU1244550221.USD","LU0256863811.USD","LU1291159041.SGD","BK4581","LU2129689514.USD","LU2237443895.HKD","LU0456855351.SGD","LU0203347892.USD","LU0234570918.USD","LU2237443978.SGD","IE00BFTCPJ56.SGD","LU0942090050.USD","LU0985320562.USD","LU0124676726.USD","LU0738911758.USD","LU2087621335.USD","LU0943347566.SGD","IE000SO60NU8.SGD","LU1023059063.AUD","BK4550","IE00B19Z3B42.SGD","LU1670628061.USD","LU2089283258.USD","LU1718418525.SGD","SG9999011175.SGD","LU2089984988.USD","IE0004445239.USD","LU0795875086.SGD","BK4533","LU1074936037.SGD","IE0000B7K699.USD","LU1732799900.SGD","LU0511384066.AUD","LU0708994859.HKD","LU1430594728.SGD","LU0965509101.SGD","LU0859254822.USD","LU0417517546.SGD","LU1057294990.SGD","LU0310799852.SGD","LU0912757837.SGD","LU1989771016.USD","IE00B42XCP33.USD","LU0158827948.USD","LU0256863902.USD","LU1267930573.SGD","IE00BJT1NW94.SGD","LU0795875169.SGD","LU0661504455.SGD","IE00B3PB1722.GBP","LU2112291526.USD","LU2347655156.SGD","IE0009355771.USD","LU2468319806.SGD","LU1244550494.USD","IE000F7OJYX1.SGD","LU0211328371.USD","LU0965509010.AUD","LU0553294199.USD","LU0114720955.EUR","SG9999015978.USD","LU1061106388.HKD","LU2237443549.SGD","IE00B2B36J28.USD","LU2129689605.HKD","LU0098860793.USD","LU0965509283.SGD","LU0432979614.USD","LU1037948897.HKD","LU1093756168.USD","LU0949170772.SGD","LU1551013425.SGD","LU1934455277.USD","LU2357627491.SGD","LU0820561818.USD","LU0868494708.USD","LU1003077747.HKD","LU1267930490.SGD","IE000WAW04H5.SGD","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147262963","title":"艾伯维旗下爱力根美学获FDA批准，Juvéderm® Skinvive用于改善颈部外观","url":"https://stock-news.laohu8.com/highlight/detail?id=1147262963","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147262963?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:03","pubTimestamp":1781611401,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已批准艾伯维公司旗下爱力根美学部门的Juvéderm Skinvive产品，用于改善成人颈部外观。该批准标志着这一透明质酸填充剂在美学应用领域获得了新的适应症。此次获批基于一项关键的临床研究数据，该研究证实了Skinvive在改善颈部皮肤质地和外观方面的有效性与安全性。作为艾伯维在医美领域的重要布局，Juvéderm系列产品此次拓展适应症，进一步巩固了其在全球填充剂市场的领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732800096.USD","IE00BBT3K403.USD","LU2112291526.USD","LU0211327993.USD","IE00B42XCP33.USD","LU2023251221.USD","LU1989772923.USD","LU1093756168.USD","LU0029864427.USD","LU0823416689.USD","IE000MB6IJN5.SGD","IE00BLSP4239.USD","BK4588","LU0203345920.USD","LU0158827948.USD","LU0114720955.EUR","LU1496350171.SGD","LU0310800379.SGD","LU0912757837.SGD","LU2347655156.SGD","LU2089284900.SGD","LU1839511570.USD","LU0128525929.USD","LU0417517546.SGD","SG9999015986.USD","LU2237443465.HKD","LU1934455194.USD","LU0069063385.USD","LU0689472784.USD","IE00BLSP4452.SGD","LU1244550494.USD","BK4533","SG9999011175.SGD","LU1267930573.SGD","LU0170899867.USD","IE0002270589.USD","LU2129689514.USD","BK4585","LU0456855351.SGD","LU0289739343.SGD","LU0553294199.USD","BK4581","LU0985320562.USD","LU0310799852.SGD","IE0009355771.USD","LU0098860793.USD","BK4566","IE00BN8TJ469.HKD","LU0234572021.USD","LU0545039389.USD","LU0868494617.USD","IE00BJT1NW94.SGD","IE000BZT7R73.USD","LU0289739699.SGD","LU1057294990.SGD","LU2468319806.SGD","LU0057025933.USD","LU0795875169.SGD","LU1496350502.SGD","SG9999015978.USD","LU1074936037.SGD","LU0689626769.HKD","LU2129689431.USD","ABBV","IE000WAW04H5.SGD","LU1718418525.SGD","IE00B3PB1722.GBP","IE00B4R5TH58.HKD","LU0942090050.USD","LU0795875086.SGD","LU1162221912.USD","LU2237443895.HKD","LU2089984988.USD","IE00BVYPNV92.GBP","LU0882574055.USD","LU1037948897.HKD","LU2237443622.USD","IE0000B7K699.USD","LU0965509010.AUD","LU1267930490.SGD","LU0965508806.USD","LU0820561818.USD","LU1732799900.SGD","IE0002141913.USD","LU0868494708.USD","IE00BFTCPJ56.SGD","LU2237443382.USD","LU2133065610.SGD","IE00BGHQF631.EUR","LU1989772840.SGD","LU0058720904.USD","IE00BVYPNW00.USD","LU1061106388.HKD","LU0234570918.USD","BK4139","LU0661504455.SGD","LU1983299246.USD","LU1037948541.HKD","LU0320765646.SGD","LU1551013342.USD","LU0289961442.SGD","LU2087621335.USD","IE00B2B36J28.USD","LU0256863811.USD","IE000SO60NU8.SGD","LU1934455863.HKD","LU0122379950.USD","IE00B19Z3581.USD","IE00BDGV0183.EUR","LU0472753341.HKD","LU2237443978.SGD","BK4559","LU1430594728.SGD","IE0004445239.USD","LU0203347892.USD","LU0198837287.USD","LU0943347566.SGD","SG9999015952.SGD","IE00B19Z3B42.SGD","LU0820561909.HKD","LU2237443549.SGD","LU0708994859.HKD","LU1093756325.SGD","LU2089283258.USD","LU1929549753.HKD","BK4534","LU1585245621.USD","LU1291159041.SGD","LU2129689605.HKD","SG9999003800.SGD","LU0738911758.USD","LU1670628061.USD","LU2357627491.SGD","LU1244550221.USD","LU0859254822.USD","LU0861579265.USD","LU0949170772.SGD","LU1551013425.SGD","LU0511384066.AUD","LU0965509283.SGD","LU1934455277.USD","LU1003077747.HKD","IE00BJJMRZ35.SGD","LU0124676726.USD","SG9999001440.SGD","BK4550","SG9999015945.SGD","LU0965509101.SGD","IE000F7OJYX1.SGD","LU1023059063.AUD","LU1989771016.USD","LU0256863902.USD","LU0211328371.USD","LU0432979614.USD","LU1244550577.SGD","IE00BSNM7G36.USD","LU1670627923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180617603","title":"异动解读｜艾伯维公司盘中下跌3.07%，报222.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1180617603","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180617603?lang=zh_cn&edition=full","pubTime":"2026-06-15 23:01","pubTimestamp":1781535695,"startTime":"0","endTime":"0","summary":"6月15日，艾伯维公司盘中下跌3.07%，报222.22美元/股，成交额2.26亿美元。艾伯维公司所在的生物科技行业中，个股表现分化，其中Regentis Biomaterials Ltd.涨154.0%，福泰制药涨1.34%，安进涨0.79%，吉利德科学涨0.25%，再生元制药公司跌0.0%。艾伯维公司是一家全球性的、以研究为基础的生物制药公司，产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎、牛皮癣和克罗恩病等，同时覆盖HIV、帕金森病及囊性纤维化等多个治疗领域。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbvie.com","stockEarnings":[{"period":"1week","weight":0.0719},{"period":"1month","weight":0.1558},{"period":"3month","weight":0.1705},{"period":"6month","weight":0.1013},{"period":"1year","weight":0.3557},{"period":"ytd","weight":0.1013}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":-0.0128},{"period":"3month","weight":0.1397},{"period":"6month","weight":0.0951},{"period":"1year","weight":0.2087},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":-0.019222},{"month":2,"riseRate":0.857143,"avgChangeRate":0.039081},{"month":3,"riseRate":0.714286,"avgChangeRate":0.001102},{"month":4,"riseRate":0.571429,"avgChangeRate":0.006536},{"month":5,"riseRate":0.642857,"avgChangeRate":0.004172},{"month":6,"riseRate":0.5,"avgChangeRate":0.019288},{"month":7,"riseRate":0.538462,"avgChangeRate":0.01232},{"month":8,"riseRate":0.538462,"avgChangeRate":0.007409},{"month":9,"riseRate":0.538462,"avgChangeRate":0.014941},{"month":10,"riseRate":0.615385,"avgChangeRate":0.007438},{"month":11,"riseRate":0.769231,"avgChangeRate":0.063841},{"month":12,"riseRate":0.692308,"avgChangeRate":0.025718}],"exchange":"NYSE","name":"艾伯维公司","nameEN":"AbbVie"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾伯维公司,ABBV,艾伯维公司股票,艾伯维公司股票老虎,艾伯维公司股票老虎国际,艾伯维公司行情,艾伯维公司股票行情,艾伯维公司股价,艾伯维公司股市,艾伯维公司股票价格,艾伯维公司股票交易,艾伯维公司股票购买,艾伯维公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}